Cary Kochman, one of Citigroup's top dealmakers, is retiring after spending nearly 14 years at the helm of the Wall Street bank's mergers and acquisitions group, people familiar with the matter told R
C's solid growth prospects on the back of business transformation look encouraging. Yet, regulatory issues and rising credit losses are concerning.
American Airlines chooses Citi as sole credit card partner, drops Barclays
Citigroup began rolling out on Wednesday new artificial intelligence tools to be used by employees in eight countries, senior executives said.
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The Citigroup Inc. 2024" company profile has been added to ResearchAndMarkets.com's offering.
President-elect Donald Trump's potential tariffs may result in more business for the bank as clients re-evaluate trading partners and supply chains.
Lazard has hired veteran Citigroup investment banker Chris Miller as a managing director to help drive its dealmaking efforts in the energy industry, people familiar with the matter told Reuters on Tu
Warren Buffett and his company, Berkshire Hathaway, have made a name for themselves by generating great returns for decades. That, coupled with the power of time and compounding, has led Berkshire's s
Berkshire Hathaway's portfolio includes diverse blue chips and lesser-known growth stocks, with 25 dividend-paying stocks analyzed for yield-based investment opportunities. Top Berkshire dividend stoc
Warren Buffett's long-term success in the stock market is undeniable. Since becoming CEO of Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has delivered 20% annually to its investors.
Strategists at Citigroup say investors are increasingly giving up on bets against the U.S. stock market.
Banks that issue credit cards used by millions of consumers raised interest rates and introduced new fees in response to an impending regulation that most experts believe will never take effect. Synch
Citigroup (C) closed the most recent trading day at $71.39, moving +0.73% from the previous trading session.
FOSTER CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio
C nears divesting Banamex as part of its restructuring efforts to exit the retail banking business in some markets and invest in sectors with high potential.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE